The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy: Chagas disease, denervation and arrhythmia

Journal of Nuclear Cardiology

Volumn 25, Issue 1, 2018, Pages 75-83

  Gadioli, Leonardo Pippa ^a   Miranda, Carlos Henrique ^a   Pintya, Antonio Osvaldo ^a   de Figueiredo, Alexandre Baldini ^a   Schmidt, André ^a   Maciel, Benedito Carlos ^a   Marin Neto, José Antonio ^a   Simões, Marcus Vinicius ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic Chagas cardiomyopathy; myocardial fibrosis; myocardial sympathetic denervation; ventricular arrhythmias

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; CHAGAS CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART DENERVATION; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MALE; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SYMPATHETIC INNERVATION; AGED; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FIBROSIS; HEART; HEART ARRHYTHMIA; HEART VENTRICLE; MIDDLE AGED; PATHOLOGY; PERFUSION; SEVERITY OF ILLNESS INDEX; SYMPATHECTOMY; SYSTOLE;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CHAGAS CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; HEART; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PERFUSION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYMPATHECTOMY; SYSTOLE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84977151306     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-016-0556-6     Document Type: Article

References (31)

1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al Control of neglected tropical diseases. N Engl J Med 2007;357:1018-27.
2. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009;49:e52-4.
3. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010;115:22-7.
4. Mendoza I, Moleiro F, Marques J. Sudden death in Chagas’ disease. Arquivos brasileiros de cardiologia 1992;59:3-4.
5. Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas’ disease. Arquivos brasileiros de cardiologia 2001;76:75-96.
6. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-402.
7. Sarabanda AV, Sosa E, Simoes MV, Figueiredo GL, Pintya AO, Marin-Neto JA. Ventricular tachycardia in Chagas’ disease: A comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms. Int J Cardiol 2005;102:9-19.
8. Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simoes MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med 2011;52:504-10.
9. Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 2006;355:799-808.
10. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
11. Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M, et al Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802-12.
12. Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simoes MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC Cardiovasc Imaging 2009;2:164-72.
13. Simoes MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol 2000;86:975-81.
14. Marin-Neto JA, Marzullo P, Marcassa C, Gallo Junior L, Maciel BC, Bellina CR, et al Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992;69:780-4.
15. Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I, et al Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation 1996;94:1010-7.
16. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol 2005;46:1553-8.
17. Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D, et al Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease. Arquivos brasileiros de cardiologia 2012;98:421-30.
18. Sosa E, Scanavacca M, d’Avila A, Fukushima J, Jatene A. Long-term results of visually guided left ventricular reconstruction as single therapy to treat ventricular tachycardia associated with postinfarction anteroseptal aneurysm. J Cardiovasc Electrophysiol 1998;9:1133-43.
19. Kasama S, Toyama T, Kaneko Y, Iwasaki T, Sumino H, Kumakura H, et al Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events. Eur J Nucl Med Mol Imaging 2012;39:1056-64.
20. Manco JC, Gallo L Jr, Godoy RA, Fernandes RG, Amorim DS. Degeneration of the cardiac nerves in Chagas’ disease. Further studies. Circulation 1969;40:879-85.
21. Amorim DS, Mello de Oliveira JA, Manco JC, Gallo L Jr, Meira de Oliveira JS. Chagas’ heart disease. First demonstrable correlation between neuronal degeneration and autonomic impairment. Acta Cardiol 1973;28:431-40.
22. Marin-Neto JAGJL, Manço JC, Rassi A, Amorim DS. Postural reflexes in chronic Chagas’ heart disease: heart rate and arterial pressure responses. Cardiology 1975;60:343-57.
23. Oria JRJ. Alterações do metassimpático do coração nos portadores de megaesôfago. Arquivos brasileiros de cardiologia 1949;2:311-6.
24. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007;115:1109-23.
25. Terai H, Shimizu M, Ino H, Yamaguchi M, Uchiyama K, Oe K, et al Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy. J Nucl Med 2003;44:1612-7.
26. Paul M, Wichter T, Kies P, Gerss J, Wollmann C, Rahbar K, et al Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias. J Nucl Med 2011;52:1559-65.
27. Paul M, Schafers M, Kies P, Acil T, Schafers K, Breithardt G, et al Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging 2006;33:866-70.
28. Daliento L, Folino AF, Menti L, Zanco P, Baratella MC, Dalla Volta S. Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot. J Am Coll Cardiol 2001;38:2043-7.
29. Mitrani RD, Klein LS, Miles WM, Hackett FK, Burt RW, Wellman HN, et al Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993;22:1344-53.
30. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:2769-77.
31. Marshall A, Cheetham A, George RS, Mason M, Kelion AD. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention. Heart 2012;98:1359-65.